Lower SARS-CoV-2 Seroprevalence among Cancer Patients in Sub-Saharan Africa.

For Yue TsoSalum J LidengeJohn R NgowiPhoebe B PeñaAshley A CleggOwen NgalamikaChacha J MwitaJulius MwaiselageCharles Wood

Published in: Journal of clinical medicine (2022)

Cancer patients in SSA tend to have a relatively lower SARS-CoV-2 seroprevalence compared to potential blood donors recruited from the same geographic locations during the COVID-19 pandemic. More study is required to determine its cause and potential impact on SARS-CoV-2 vaccination among cancer patients.

Keyphrases

sars cov
respiratory syndrome coronavirus
human health
risk assessment
coronavirus disease